1. Home
  2. UDMY vs AVDL Comparison

UDMY vs AVDL Comparison

Compare UDMY & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

HOLD

Current Price

$5.30

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.39

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDMY
AVDL
Founded
2009
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
2.1B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
UDMY
AVDL
Price
$5.30
$21.39
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$9.63
$18.38
AVG Volume (30 Days)
1.8M
2.8M
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$795,801,000.00
$248,517,000.00
Revenue This Year
$2.34
$65.47
Revenue Next Year
$2.54
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
2.53
79.88
52 Week Low
$4.86
$6.38
52 Week High
$10.61
$23.57

Technical Indicators

Market Signals
Indicator
UDMY
AVDL
Relative Strength Index (RSI) 46.97 58.68
Support Level $5.02 $21.29
Resistance Level $5.30 $21.55
Average True Range (ATR) 0.17 0.25
MACD 0.09 -0.26
Stochastic Oscillator 51.45 9.50

Price Performance

Historical Comparison
UDMY
AVDL

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: